Casdin Capital

Latest statistics and disclosures from Casdin Capital's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Casdin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Casdin Capital

Casdin Capital holds 36 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Revolution Medicines (RVMD) 16.1 $164M +215% 5.7M 28.68
 View chart
Biolife Solutions Com New (BLFS) 13.9 $142M +11% 8.7M 16.25
 View chart
Sarepta Therapeutics (SRPT) 9.5 $97M 1.0M 96.43
 View chart
Relay Therapeutics (RLAY) 8.0 $81M +6% 7.4M 11.01
 View chart
Illumina Call Option (ILMN) 4.6 $47M +576% 338k 139.24
 View chart
Structure Therapeutics Sponsored Ads Call Option (GPCR) 4.5 $46M -11% 1.1M 40.76
 View chart
Intellia Therapeutics (NTLA) 4.3 $44M +23% 1.5M 30.49
 View chart
Verve Therapeutics (VERV) 4.1 $42M 3.0M 13.94
 View chart
Alnylam Pharmaceuticals (ALNY) 3.7 $37M -11% 195k 191.41
 View chart
Somalogic Class A Com 3.1 $32M 13M 2.53
 View chart
EXACT Sciences Corporation (EXAS) 3.1 $31M -8% 420k 73.98
 View chart
Blueprint Medicines (BPMC) 3.0 $30M -12% 326k 92.24
 View chart
Pliant Therapeutics (PLRX) 2.8 $29M 1.6M 18.11
 View chart
Denali Therapeutics (DNLI) 2.7 $28M 1.3M 21.46
 View chart
4d Molecular Therapeutics In (FDMT) 2.1 $21M 1.0M 20.26
 View chart
Tenaya Therapeutics (TNYA) 2.0 $21M 6.4M 3.24
 View chart
Beam Therapeutics (BEAM) 1.4 $14M -7% 528k 27.22
 View chart
Abcellera Biologics (ABCL) 1.3 $14M 2.4M 5.71
 View chart
Tango Therapeutics (TNGX) 1.2 $12M -9% 1.2M 9.90
 View chart
Century Therapeutics (IPSC) 1.0 $11M 3.2M 3.32
 View chart
Avidity Biosciences Ord (RNA) 1.0 $11M -5% 1.2M 9.05
 View chart
Neurogene 1.0 $10M NEW 525k 19.38
 View chart
Pacific Biosciences of California (PACB) 1.0 $10M 1.0M 9.81
 View chart
Genedx Holdings Corp Com Cl A (WGS) 0.8 $8.5M 3.1M 2.75
 View chart
Fate Therapeutics (FATE) 0.8 $7.7M 2.1M 3.74
 View chart
Codexis (CDXS) 0.6 $6.1M +566% 2.0M 3.05
 View chart
2seventy Bio Common Stock (TSVT) 0.5 $5.0M -41% 1.2M 4.27
 View chart
Absci Corp (ABSI) 0.4 $4.1M 973k 4.20
 View chart
Prime Medicine (PRME) 0.3 $3.3M 367k 8.86
 View chart
Syndax Pharmaceuticals (SNDX) 0.3 $3.2M NEW 150k 21.61
 View chart
Monte Rosa Therapeutics (GLUE) 0.3 $2.9M 511k 5.65
 View chart
D Fluidigm Corp Del (LAB) 0.3 $2.7M 1.2M 2.21
 View chart
Exscientia Ads (EXAI) 0.1 $1.4M 214k 6.41
 View chart
Lianbio Sponsored Ads (LIAN) 0.1 $923k 206k 4.47
 View chart
Singular Genomics Systems In (OMIC) 0.1 $609k 1.3M 0.46
 View chart
Kronos Bio (KRON) 0.0 $155k 124k 1.25
 View chart

Past Filings by Casdin Capital

SEC 13F filings are viewable for Casdin Capital going back to 2015

View all past filings